What are the recommended dosing regimens for cefepime and piperacillin/tazobactam (Zosyn) in an adult, and how should they be adjusted for impaired renal function?

Cefepime and Piperacillin/Tazobactam (Zosyn) Dosing

For adults with normal renal function, cefepime should be dosed at 2 g IV every 8-12 hours, and piperacillin/tazobactam (Zosyn) at 3.375 g IV every 6 hours or 4.5 g IV every 6-8 hours, with both requiring renal dose adjustments based on creatinine clearance.

Standard Dosing for Normal Renal Function

Cefepime

• Standard dose: 2 g IV every 8-12 hours 1, 2
• For severe infections (ICU pneumonia, septic shock): 2 g IV every 8 hours 2
• For Pseudomonas coverage in critically ill: Consider 2 g every 8 hours 3

Piperacillin/Tazobactam (Zosyn)

• Standard dose: 3.375 g IV every 6 hours 1, 2
• Alternative: 4.5 g IV every 6-8 hours 1, 2
• For Pseudomonas infections: 3.375 g every 4 hours or 4.5 g every 6 hours 1

Critical Considerations for Dosing Optimization

Extended/Prolonged Infusions

For severe infections and critically ill patients, prolonged infusions significantly improve pharmacodynamic target attainment 4, 5, 6:

• Piperacillin/tazobactam: Infuse 3.375 g over 4 hours every 6 hours OR 4.5 g over 3 hours every 6-8 hours 7, 5
• Cefepime: Consider 2 g infused over 3 hours every 8 hours for resistant organisms 6
• Rationale: β-lactams achieve optimal killing when free drug concentration remains above the MIC for 100% of the dosing interval (100% fT>MIC), particularly in sepsis 4, 5

Loading Doses in Sepsis/Septic Shock

For critically ill patients, administer full loading doses immediately to rapidly achieve therapeutic levels 4, 5:

• Standard doses can be given as bolus initially
• Loading doses are NOT affected by renal dysfunction 4, 5
• Volume expansion from fluid resuscitation increases volume of distribution, necessitating adequate loading 5

Renal Dose Adjustments

Cefepime Renal Dosing

Adjust based on creatinine clearance (CrCl):

CrCl (mL/min)	Recommended Dose
>60	2 g every 8-12 h (no adjustment)
30-60	2 g every 12-24 h
10-29	1 g every 24 h
<10	500 mg every 24 h
Hemodialysis	1 g after each dialysis session

Critical warning: Cefepime has high neurotoxic potential, especially with renal impairment 6. Trough concentrations >64 mg/L are associated with 50% risk of neurotoxicity 6. In patients with renal dysfunction or pre-existing neurological conditions, monitor closely for altered mental status, seizures, or encephalopathy 8, 9.

Piperacillin/Tazobactam Renal Dosing

Adjust based on CrCl 10, 11:

CrCl (mL/min)	Recommended Dose
>40	3.375 g every 6 h OR 4.5 g every 6-8 h (no adjustment)
20-40	2.25 g every 6 h OR 3.375 g every 8 h
<20	2.25 g every 8 h
Hemodialysis	2.25 g every 12 h (plus 0.75 g after each dialysis)

For prolonged infusions with renal impairment: 4.5 g or 3.375 g every 8 hours (infused over 4 hours) for CrCl 20-40 mL/min; every 12 hours for CrCl <20 mL/min 7, 11.

Special Populations

Augmented Renal Clearance (CrCl >130 mL/min)

Common in young, critically ill patients without baseline kidney disease:

• Cefepime: May require 2 g every 8 hours with prolonged infusion OR continuous infusion (2 g loading, then 4 g/day continuous) 9
• Piperacillin/tazobactam: 4.5 g every 6 hours with prolonged infusion 7

Obesity

• Cefepime: Use actual body weight for dosing; no specific adjustment needed beyond standard dosing 12
• Piperacillin/tazobactam: Use actual body weight; standard doses appropriate 12

Low Body Weight (BMI ≤18.5 kg/m²)

• Dosing should be guided primarily by renal function, not body weight 13
• Prolonged infusions improve target attainment in this population 13

Common Pitfalls to Avoid

1. Underdosing in augmented renal clearance: Young, critically ill patients often have CrCl >130 mL/min and require higher/more frequent dosing 9, 7

2. Cefepime neurotoxicity: Risk increases dramatically with renal impairment. Reduce dose aggressively when CrCl <60 mL/min 6, 8. Monitor for confusion, myoclonus, seizures.

3. Inadequate dosing for Pseudomonas: Both drugs require higher doses for Pseudomonas coverage (MIC typically 8-16 mg/L). Use 4.5 g piperacillin/tazobactam every 6 hours or 2 g cefepime every 8 hours with prolonged infusions 14, 3, 2.

4. Vancomycin + piperacillin/tazobactam nephrotoxicity concerns: While creatinine elevations occur more frequently with this combination, recent evidence suggests this represents "pseudo-nephrotoxicity" rather than clinically meaningful kidney injury, as progression to dialysis or death is not increased 15. Monitor renal function but do not avoid this combination when clinically indicated.

5. Forgetting to adjust for intermittent hemodialysis: Both drugs are significantly removed by dialysis. Always dose after dialysis sessions 11, 16.

Therapeutic Drug Monitoring

Consider TDM for:

• Critically ill patients with septic shock 4, 5
• Augmented or impaired renal clearance 8, 9
• Suspected treatment failure
• Target for β-lactams: 100% fT>MIC (free drug concentration above MIC for entire dosing interval) 4, 5, 6